221 results on '"Soubeyran I"'
Search Results
2. Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
3. 10P Deep learning-based prediction of patient’s TLS status from HE images in pan-cancer cohort
4. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth
5. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer
6. Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
7. Therapeutic strategies in elderly and very elderly patients
8. A clinical case of invasive lobular breast carcinoma with ERBB2 and CDH1 mutations presenting a dramatic response to anti-HER2-directed therapy
9. 159P SiMosein, a real-life prospective evaluation of EndoPredict use in early ER-positive, HER2-negative breast cancers
10. 1920MO Regomune: A phase II study of regorafenib + avelumab in solid tumors - Results of the advanced or metastatic gastrointestinal stromal tumors (mGIST) cohort
11. 1634P Extensive molecular profiling of KRAS wild-type versus KRAS mutant pancreatic ductal adenocarcinoma on 233 patients
12. 705P TIMES: A ctDNA tumor fraction based and externally validated nomogram to predict survival in cancer patients referred for early phase trials
13. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas
14. Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories
15. BENEFITS OF THE ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION (EUS-FNA) FOR THE EVALUATION OF HYPERMETABOLIC MEDIASTINAL LYMPHADENOPATHY DETECTED BY PET-CT WITH 18F-FDG (PET) (APOGEE STUDY)
16. 1719P Predictive value of DNA repair gene alterations for the response to platinum-based chemotherapy and immunotherapy in advanced solid tumors patients: Results from a single center molecular screening program
17. 1494P Regomune - a phase II study of regorafenib + avelumab in solid tumors: Results of the soft tissue sarcoma (STS) cohort
18. 1084P Predicting KRAS G12C subtype from non-small cell lung cancer H&E slides using deep learning
19. Clinical impact of a comprehensive molecular approach in advanced gynecologic tumors
20. ID: 1023 All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth
21. BRCA1&2 tumoral and germline status for ovarian cancer patients in first line setting within the PAOLA-01 trial
22. IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis
23. Abstract PD1-08: High-throughput genome analysis and therapeutic decision for patients with HER2-negative metastatic breast cancer: First feasibility and molecular results of the randomized phase II study SAFIR02 BREAST (UCBG-0105/1304)
24. Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)-bearing follicular non-Hodgkin's lymphoma: An exploratory study in 8 patients
25. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer
26. 63P - Clinical impact of a comprehensive molecular approach in advanced gynecologic tumors
27. 460 BIP2 (Bergonié Institute profiling program) bringing molecular profiling into routine practice in order to match molecular alterations with drugs in early phase trials
28. Biologie moléculaire des cancers anaplasiques thyroïdiens. Étude sur 144 cas
29. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
30. 1176P - IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis
31. 935PD - BRCA1&2 tumoral and germline status for ovarian cancer patients in first line setting within the PAOLA-01 trial
32. Sarcoïdose médiastinale dans un contexte oncologique : apport de la ponction aspiration guidée par échoendoscopie
33. Spectaculaire réponse sous crizotinib dans un cas de carcinome anaplasique thyroidien avec réarrangement du gène ALK
34. Analyse rétrospective multicentrique française des carcinomes à cellules de Hürhtle et valeur pronostique de 20 marqueurs miRNA
35. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas
36. R13: Exploration moléculaire par analyse cytométrique quantitative de tissue microarrays
37. R9: Potentialisation de la réponse apoptotique au Rituximab (RTX) dans les lymphomes B non hodgkinien : rôle du calcium
38. 104 Impact of diagnostic advices in cancer care in Aquitaine
39. Prognostic significance of lymphovascular invasion in node-positive patients with primary operable breast cancer
40. Accélération de la fixation par le micro-ondes : l’expérience bordelaise
41. Lymphome nasal natural killer mimant une maladie de Wegener localisée
42. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas
43. Anaplastic large cell lymphoma: clinical features and prognosis in a retrospective series of 72 patients treated in a single institution
44. Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers
45. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients
46. Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases
47. PP-6-4 Prognostic Significance of Obvious Peritumoral Emboli in 2692 Primary Operable Breast Carcinoma
48. Natural killer cell nasal lymphoma mimicking a localized Wegener's disease
49. Current treatment of Hodgkin`s disease
50. Small B-cell lymphoproliferative disorders: an overview of diagnostic approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.